Revenue: The sum of all revenue fields included for a company's operating activities.
Vertex Pharmaceuticals Incorporated (VRTX) had Revenue of $2.99B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$2.99B |
$1.03B |
|
$392.80M |
|
$2.59B |
|
$1.85B |
|
$1.14B |
|
$114.80M |
|
$1.25B |
|
$1.25B |
|
$1.03B |
|
$1.03B |
|
$1.03B |
|
$1.03B |
|
$1.14B |
|
$1.19B |
|
254.10M |
|
256.30M |
|
$4.06 |
|
$4.02 |
|
| Balance Sheet Financials | |
$11.73B |
|
$1.61B |
|
$14.75B |
|
$26.48B |
|
$3.88B |
|
-- |
|
$3.24B |
|
$7.12B |
|
$19.36B |
|
$17.86B |
|
$19.36B |
|
254.16M |
|
| Cash Flow Statement Financials | |
$1.43B |
|
$-431.90M |
|
$-538.80M |
|
$5.09B |
|
$5.50B |
|
$417.10M |
|
$166.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.85% |
|
38.10% |
|
38.10% |
|
-- |
|
41.95% |
|
34.53% |
|
$1.29B |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.22 |
|
1.50 |
|
60.15 |
|
5.33% |
|
5.78% |
|
3.89% |
|
5.33% |
|
$76.18 |
|
$5.05 |
|
$5.57 |
|